AXIM® Biotechnologies Files Patent for Virus Binding Recombinant Protein for SARS-CoV-2 (COVID-19) and Begins Manufacturing

by IR Team | Sep 30, 2020 | Press Release

SAN DIEGO, September 30, 2020 — AXIM® Biotechnologies, Inc. (OTCQB: AXIM) (“AXIM® Biotech,” “AXIM” or “the Company”), an international healthcare solutions company targeting oncological and COVID-19 research, announced today that it has filed a provisional...

AXIM® Biotechnologies Files Patent for World’s First Face Mask Designed to Capture SARS-CoV-2 COVID-19

by IR Team | Sep 29, 2020 | Press Release

SAN DIEGO, September 29, 2020 — AXIM® Biotechnologies, Inc. (OTCQB: AXIM) (“AXIM® Biotech,” “AXIM” or “the Company”), an international healthcare solutions company targeting oncological and COVID-19 research, announced today that it has filed a provisional...

AXIM® Biotechnologies Receives Notice of U.S. Patent Allowance for Proprietary Compounds and Methods Targeting Tumor Metastasis Through QSOX1

by IR Team | Sep 22, 2020 | Press Release

SAN DIEGO – September 22, 2020 – AXIM® Biotechnologies, Inc. (OTCQB: AXIM) (“AXIM® Biotech,” “AXIM” or “the Company”), an international healthcare solutions company targeting oncological and COVID-19 research, announced today that the United States Patent and...

Coronavirus company news summary – Color receives EUA for Covid-19 self-collection kit – Vivera Pharmaceuticals launches BIOZONE device

by IR Team | Sep 17, 2020 | News

AXIM Biotechnologies has filed an Emergency Use Authorisation (EUA) application with the US Food and Drug Administration (FDA) for its first-in-class rapid diagnostic test for Covid-19. AXIM’s rapid diagnostic test is expected to be the market’s first Covid-19 rapid...

AXIM Biotechnologies files EUA with FDA for Covid-19 rapid diagnostic test for neutralising antibodies

by IR Team | Sep 17, 2020 | News

AXIM’s rapid diagnostic test is expected to be the market’s first Covid-19 rapid diagnostic test for measuring levels of functional neutralising antibodies in a lateral flow assay format. AXIM Biotechnologies, an international healthcare solutions company targeting...